Search Within

Susan E Prockop

  1. "Richard O'Reilly"
Formats
  1. Meeting Abstract (115)
  2. Journal Article (43)
  3. Conference Paper (1)
  4. Review (1)
Groups
  1. Department of Medicine (160)
  2. GSK Faculty (160)
  3. Immunology Program Faculty (160)
  4. Pediatrics, Department of (160)
  5. Sloan Kettering Institute Faculty (160)
  6. Stem Cell Transplantation and Cellular Therapy Service (160)

More Groups

People
  1. Richard O'Reilly (160)
  2. Nancy Kernan (113)
  3. Farid Boulad (104)
  4. Andromachi Scaradavou (81)
  5. Esperanza Papadopoulos (54)
  6. Trudy Small (49)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (5)
  4. 2021 (4)
  5. 2020 (18)
  6. 2019 (13)

More Years

Publications
  1. Blood (63)
  2. Biology of Blood and Marrow Transplantation (48)
  3. Bone Marrow Transplantation (17)
  4. Cytotherapy (6)
  5. Transplantation and Cellular Therapy (5)
  6. Blood Advances (3)

More Publications

Publishers
  1. American Society of Hematology (66)
  2. Elsevier Inc. (54)
  3. Nature Publishing Group (17)
  4. Elsevier Science Ltd. (6)
  5. American Society of Clinical Oncology (3)
  6. Wiley Periodicals, Inc (3)

More Publishers

Results (160)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment with banked 3rd party donor derived virus specific T cells: The advantages of pre-defined HLA restriction and epitope specificity
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A.; O'Reilly, R. J.
    Cytotherapy (2020)

    Fulltext@MSK | Save
  • Epstein-Barr virus-specific cytotoxic T lymphocyte precursors (EBV-CTLp) after tabelecleucel correlates with response & survival in rituximab relapsing or refractory EBV posttransplant lymphoproliferative disease (PTLD)
    Meeting Abstract

    Prockop, S.; Shen, R. R.; Guzman-Becerra, N.; Sun, Y.; Forozan, F.; Doubrovina, E.; O'Reilly, R. J.; Li, X.; Hiremath, M.; Gamelin, L.; more...
    Cytotherapy (2020)

    Fulltext@MSK | Save
  • Correlation of Epstein-Barr virus-specific cytotoxic T lymphocyte precursors (EBV-CTLp) after tabelecleucel with response and survival in rituximab relapsing or refractory EBV plus post-transplant lymphoproliferative disease (PTLD)
    Meeting Abstract

    Aftab, B. T.; Shen, R. R.; Guzman-Becerra, N.; Sun, Y.; Forozan, F.; Prockop, S.; Doubrovina, E.; O'Reilly, R. J.; Li, X.; Hiremath, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Baseline immune status predicts response to adoptive therapy with CMV cytotoxic T-Cells for refractory CMV
    Meeting Abstract

    Fabrizio, V.; Rodriguez-Sanchez, I.; Mauguen, A.; Dahi, P. B.; O'Reilly, R. J.; Prockop, S. E.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Host T-cells contribute to immune reconstitution and improved outcome in recipients of CD34 selected T-cell depleted allografts (TCD HCT) with full hematopoietic cell but persistent mixed T-cell chimerism
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Heller, G.; Boulad, F.; Castro-Malaspina, H.; Giralt, S. A.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Early CD4+ T cell reconstruction as predictor for outcomes after allogeneic hematopoietic cell transplantation in pediatric and young adult patients: A validation cohort analyses
    Meeting Abstract

    Van Roessel, I.; Prockop, S. E.; Klein, E.; Boulad, F.; Scaradavou, A.; Spitzer, B.; Kung, A.; Curran, K.; Cancio, M.; O'Reilly, R. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Early CD4+ T-cell reconstitution is an excellent predictor for survival and non-relapse mortality in pediatric and young adult patients who develop moderate to severe acute graft-versus-host-disease; a dual center validation
    Meeting Abstract

    de Koning, C.; Prockop, S. E.; Van Roessel, I.; Klein, E.; Boulad, F.; Kernan, N. A.; Scaradavou, A.; Curran, K. J.; Spitzer, B.; Cancio, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Rabbit anti-thymocyte globulin (ATG) exposure after ex vivo T-cell depleted hematopoietic cell transplantation is highly variable and impacts immune reconstitution in pediatric and young adult patients
    Meeting Abstract

    Lakkaraja, M.; Mauguen, A.; Boulad, F.; Spitzer, B.; Scaradavou, A.; Curran, K. J.; Cancio, M.; van Roessel, I.; Kernan, N. A.; O'Reilly, R. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save